Wyeth and Impax settle Effexor XR patent case (News-Medical-Net)

Wyeth and Impax settle Effexor XR patent case (News-Medical-Net)
Wyeth and Impax Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining to Impax’s proposed generic capsule formulation of Wyeth’s Effexor XR antidepressant have been approved by the United States District Court for the District of Delaware.